Edition:
United States

PharMerica Corp (PMC.N)

PMC.N on New York Stock Exchange

29.20USD
22 Nov 2017
Change (% chg)

$0.05 (+0.17%)
Prev Close
$29.15
Open
$29.15
Day's High
$29.20
Day's Low
$29.12
Volume
32,969
Avg. Vol
66,114
52-wk High
$29.50
52-wk Low
$22.05

Latest Key Developments (Source: Significant Developments)

PharMerica Q3 2017 adjusted earnings per share $0.46
Thursday, 9 Nov 2017 03:00pm EST 

Nov 9 (Reuters) - PharMerica Corp ::PharMerica reports third quarter 2017 results.Q3 adjusted earnings per share $0.46.Q3 earnings per share $0.10.Q3 earnings per share view $0.50 -- Thomson Reuters I/B/E/S.Q3 revenue $595.1 million versus i/b/e/s view $602.4 million.PharMerica - ‍in light of agreement with KKR & Walgreens Boots Alliance, co does not intend to hold earnings conference calls during pendency of transaction​.  Full Article

PharMerica announces approval of merger by stockholders
Thursday, 9 Nov 2017 02:01pm EST 

Nov 9 (Reuters) - PharMerica Corp ::PharMerica announces approval of merger by stockholders.More than 99% of votes cast, representing about 79% shares of co's common stock were cast in favor of adopting merger agreement​.  Full Article

Pharmerica reports Q2 EPS $0.15
Wednesday, 2 Aug 2017 07:01am EDT 

Aug 2 (Reuters) - Pharmerica Corp :Pharmerica reports second quarter 2017 results.Q2 adjusted earnings per share $0.47.Q2 earnings per share $0.15.Q2 earnings per share view $0.47 -- Thomson Reuters I/B/E/S.Q2 revenue $592 million versus I/B/E/S view $593 million.In light of agreement with KKR and Walgreens Boots Alliance, Pharmerica has cancelled its Q2 2017 earnings conference call.Q2 2017 earnings conference call was previously scheduled to be held on August 4, 2017, at 10:00 a.m. Eastern time.  Full Article

PharMerica Corp enters to be acquired by KKR for $29.25 per share in cash
Wednesday, 2 Aug 2017 07:00am EDT 

Aug 2 (Reuters) - PharMerica Corp :PharMerica Corporation enters into definitive agreement to be acquired by KKR for $29.25 per share in cash.PharMerica corporation says acquisition agreement was unanimously approved by the board of directors of PharMerica .PharMerica Corporation says KKR is making the investment primarily through its Americas XII fund.PharMerica Corporation says Walgreens Boots Alliance intends to account for its minority ownership interest in PharMerica as an equity method investment.All-Cash transaction is valued at approximately $1.4 billion including the assumption or repayment of debt.PharMerica Corporation says in light of the agreement with KKR and Walgreens, PharMerica has cancelled its second quarter 2017 earnings conference call.PharMerica Corp - upon completion of the transaction, PharMerica will become a private company‍​.  Full Article

Pharmerica acquires Caremed Specialty Pharmacy
Thursday, 16 Mar 2017 04:15pm EDT 

Pharmerica Corp : Pharmerica acquires CareMed Specialty Pharmacy .Pharmerica Corp - terms of transaction were not disclosed..  Full Article

Pharmerica posts Q4 EPS of $0.25
Friday, 24 Feb 2017 08:00am EST 

Pharmerica Corp : Pharmerica reports fourth quarter and full year 2016 results . Q4 adjusted earnings per share $0.58 . Q4 earnings per share $0.25 . Q4 revenue $534.4 million versus I/B/E/S view $525.2 million . Sees fy 2017 adjusted earnings per share $1.75 to $1.95 . Sees fy 2017 revenue $2.3 billion to $2.4 billion . Q4 earnings per share view $0.51 -- Thomson Reuters I/B/E/S . Pharmerica corp - in diversified pharmacy businesses, we expect that annualized revenues in second half of 2017 will be greater than one billion dollars .Fy2017 earnings per share view $2.18, revenue view $2.24 billion -- Thomson Reuters I/B/E/S.  Full Article

Pharmerica Corp announces planned retirement of CFO David Froesel jr.
Tuesday, 9 Aug 2016 08:01am EDT 

Pharmerica Corp : Pharmerica Corporation announces planned retirement of chief financial officer david w. Froesel, jr. . Froesel will continue as chief financial officer through end of september 2016 .Has initiated a comprehensive search process to identify froesel's successor.  Full Article

Pharmerica Q2 adjusted EPS $0.47
Tuesday, 9 Aug 2016 08:00am EDT 

Pharmerica Corp : Pharmerica reports second quarter 2016 results . Q2 revenue $519.6 million versus I/B/E/S view $508.3 million . Sees FY 2016 adjusted earnings per share $1.95 to $2.05 . Q2 earnings per share view $0.47 -- Thomson Reuters I/B/E/S . Q2 earnings per share $0.08 . Sees fy 2016 revenue $2.125 billion to $2.15 billion .FY2016 earnings per share view $2.02, revenue view $2.12 billion -- Thomson Reuters I/B/E/S.  Full Article

Pharmerica posts Q1 earnings of $0.13/share
Friday, 6 May 2016 08:31am EDT 

Pharmerica Corp : Pharmerica reports first quarter 2016 results . Q1 adjusted earnings per share $0.45 . Q1 earnings per share $0.13 . Q1 revenue $524.5 million versus I/B/E/S view $509.5 million . Q1 earnings per share view $0.43 -- Thomson Reuters I/B/E/S . Sees FY 2016 adjusted earnings per share $1.95 to $2.05 . Sees FY 2016 revenue $2.125 billion to $2.15 billion . Reaffirms annual 2016 guidance .FY 2016 earnings per share view $2.01, revenue view $2.13 billion -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-PharMerica Q3 2017 adjusted earnings per share $0.46

* Q3 earnings per share view $0.50 -- Thomson Reuters I/B/E/S